PIA
FBRX icon

Piedmont Investment Advisors’s Forte Biosciences FBRX Stock Holding History

Piedmont Investment Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$3K – 1448
2018
Q2 		$3K Buy
+1
New +$3.66K ﹤0.01% 2374

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Piedmont Investment Advisors's FBRX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Forte Biosciences (FBRX) in Q3 2018, closing a stake of 1 share — an estimated $3K sold.

Piedmont Investment Advisors first reported a position in FBRX in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 63 funds tracked by Wall St. Rank hold FBRX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Forte Biosciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1 Forte Biosciences share in Q3 2018, an estimated $3K.
  • Piedmont Investment Advisors first reported a position in Forte Biosciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Forte Biosciences position peaked at $3K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.